Protein-protein interactions (PPIs) are challenging drug targets due to their large and shallow interaction surfaces and high false positive hit rates from high-throughput screening (HTS).

This poster highlights the successful development of a label-free MicroScale Thermophoresis (MST) assay to validate inhibitors of the Nrf2-Keap1 interaction.